Enzolytics Inc (ENZC)

[OTCShotCaller]

Yes Cytodyn (CYDY)

Like ENZC they have a Patent on a Monoclonal Ab, i.e. "Leronlim" for treating HIV that is FAR inferior to ENZC's Clone-3.

Clone-3 has been proven to prevent "Viral Escape" in 95% of all known HIV strains worldwide. Therefore, it is a curative treatment for HIV, the first in world history, thus "Disruptive Biotechnology."

Enzc's Clone-3 Patent is worth $Billions$" in the landscape of the Global HIV drug treatment market alone. This does NOT include several of its other potential applications for possibly curing Covid-19 currently under investigation at Texas A&M drug development center. Other potential applications include treating/curing several other deadly viral diseases that have plagued Humanity for centuries.

Cytodyn's Leronlim Antibody, unlike Enzc's Clone-3, displays "Viral Escape" AND it has all kinds of terrible side effects. It is also required to be administered in conjunction with the HIV Standard Of Care Cocktails of 3-5 additional drugs 3X per week.

At best the Leronlim antibody helps to facilitate reduction in viral load in some but not all patients depending on the overall health of the patient, age, over lapping clinical conditions, etc.

Here's the clincher 1). to date Cytodyn, as far as I know, still has not brought their Leronlim Antibody drug to market; and 2). their 52-Week trading history shows their stock ran from a PPS of $0.26 to $10, and settled back to $4.66 where it is today. Their current history shows a low of 0.79, but that is not the lowest its been.

I hope this helps.

Be well and prosper...